Cardihab

Cardihab enables clinicians to remotely deliver a scientifically validated, comprehensive Phase II CR program according to ACRA guidelines. In the world's first randomized controlled trial, CSIRO and Queensland Health researchers demonstrated that remote delivery of CR can increase patient uptake (+29%), adherence (+38%), and completion rates (+70%), while significantly reducing the number of center visits (providing the same clinical outcomes compared to traditional center-based Phase II rehabilitation programs).